X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/jj-janssen-pharmaceuticals-hit-with-10m-lawsuit-for-eye-damage-caused-by-prescription-drug-elmiron-301469123.html
https://www.proactiveinvestors.com.au/companies/news/930054/paradigm-biopharmaceuticals-has-clear-path-towards-zilosul-oa-phase-3-clinical-trial-and-product-registration-in-europe-930054.html
https://www.prnewswire.com/news-releases/elmironpentosan-users-who-have-developed-maculopathy-and-other-eye-issues-after-prolonged-use-james-scott-farrin-is-ready-to-fight-for-you-301095485.html
http://www.pharmafile.com/news/533511/nice-greenlights-consilient-healths-elmiron-bladder-pain-syndrome
http://www.pharmatimes.com/news/nice_recommends_elmiron_for_bladder_pain_syndrome_1316807
https://www.forbes.com/sites/robertglatter/2019/10/17/new-study-adds-concern-that-medication-to-treat-painful-bladder-condition-linked-to-vision-threatening-eye-condition/#3b4f5f911bf6
http://www.pharmatimes.com/news/elmiron_bags_draft_nice_approval_1312578
https://www.gov.uk/drug-safety-update/letters-and-drug-alerts-sent-to-healthcare-professionals-in-july-2019
https://www.pharmacompass.com/pdf/news/Bene-Arzneimittel-Gmbh-Elmiron-Pentosan-Polysulfate-Sodium-Receives-Approval-In-Europe-1498109856.pdf
http://www.pharmatimes.com/news/six_new_medicines_backed_for_eu_approval_1190077
http://www.biospace.com/News/investors-await-four-key-fda-decisions-in-the/404191/source=TopBreaking
http://www.prnewswire.com/news-releases/bene-arzneimittel-recibe-el-estatus-de-farmaco-huerfano-para-polisulfato-de-pentosan-562970331.html
Market Place
Share 
